← All Imac Holdings, INC filings

Imac Holdings, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

OTC.Pink
BACK
Imac Holdings, INC
S-1/A: IMAC Holdings Pursues $60 Million Equity Financing to Advance Proteomics Business
IMAC Holdings intends to raise up to $60 million through an equity line of credit to support its proteomics business, focusing on oncology treatment decisions.
OTC.Pink
BACK
Imac Holdings, INC
S-1/A: IMAC Holdings Eyes $60 Million Capital Injection via Equity Line with Keystone Capital Partners
IMAC Holdings plans to potentially raise up to $60 million through an equity line of credit with Keystone Capital Partners, while navigating Nasdaq compliance challenges.
OTC.Pink
BACK
Imac Holdings, INC
S-1/A: IMAC Holdings Files Amendment for Potential Resale of 35 Million Shares
IMAC Holdings has filed an amendment to its registration statement for the potential resale of up to 35,007,025 shares of common stock by Keystone Capital Partners, LLC.
OTC.Pink
BACK
Imac Holdings, INC
S-1: IMAC Holdings Eyes $20 Million Capital Raise to Fuel Precision Medicine Expansion
IMAC Holdings is seeking to raise capital through a public offering of common stock and warrants to support its strategic shift towards precision medicine with its Theralink technology.